Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.20452/pamw.15366 http://scihub22266oqcxt.onion/10.20452/pamw.15366 32426957!ä!32426957 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pol+Arch+Intern+Med 2020 ; 130 (7-8): 655-661 Nephropedia Template TP {{tp|p=32426957|t=2020. Should coronavirus disease 2019 concern rheumatologists?|pdf=|usr=}}{{32426957}} gab.com Text Should coronavirus disease 2019 concern rheumatologists JO: Pol Arch Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=32426957 #FOAvip Coronavirus disease 2019 (COVID?19) is an infectious disease that became a global health emergency. This review focuses on the aspects of COVID?19 pertaining to rheumatology, including signs and symptoms akin to those observed in rheumatic disorders, risk of infection or severe course of the disease in patients with a pre? existing rheumatic disease and those receiving antirheumatic or immunosuppressive medication, as well as potential use of antirheumatic or anticytokine therapeutic strategies that are already applied in rheumatology (among others, chloroquine, hydroxychloroquine, tocilizumab, and baricitinib) in patients with COVID?19. Twit Text FOAVip Should coronavirus disease 2019 concern rheumatologists ????Pol Arch Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=32426957 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32426957 #FOAvip English Wikipedia <ref>{{Cite pmid|32426957}}</ref> Should coronavirus disease 2019 concern rheumatologists? #MMPMID32426957 Kucharz EJ Pol Arch Intern Med 2020[Aug]; 130 (7-8): 655-661 PMID32426957show ga Coronavirus disease 2019 (COVID?19) is an infectious disease that became a global health emergency. This review focuses on the aspects of COVID?19 pertaining to rheumatology, including signs and symptoms akin to those observed in rheumatic disorders, risk of infection or severe course of the disease in patients with a pre? existing rheumatic disease and those receiving antirheumatic or immunosuppressive medication, as well as potential use of antirheumatic or anticytokine therapeutic strategies that are already applied in rheumatology (among others, chloroquine, hydroxychloroquine, tocilizumab, and baricitinib) in patients with COVID?19. |Antirheumatic Agents/therapeutic use[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Chloroquine/therapeutic use[MESH] |Coronavirus Infections/*drug therapy[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy[MESH] |Rheumatic Diseases/*drug therapy[MESH]Should coronavirus disease 2019 concern rheumatologists?(epmc).pdf DeepDyve Pubget Overpricing